Détail de l'auteur
Auteur B. WETTERMARK |
Documents disponibles écrits par cet auteur (7)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Ouvrage
Drug Utilization Research (DUR) is an eclectic scientific discipline, integrating descriptive and analytical methods for the quantification, understanding and evaluation of the processes of prescribing, dispensing and consumption of medicines an[...]Article
B. GODMAN ; B. WETTERMARK ; C. SERMET |Pharmaceutical expenditure is increasingly scrutinised by payers of health care in view of its rapid growth resulting in a variety of reforms to help moderate future growth. This includes measures across Europe to enhance the utilisation of gene[...]Article
B. GODMAN ; W. SHRANK ; M. ANDERSEN ; C. BERG ; I. BISHOP ; T. BURKHARDT ; K. GARUOLIENE ; H. HERHOLZ ; R. JOPPI ; M. KALABA ; O. LAIUS ; D. MCGINN ; V. SAMALUC ; C. SERMET ; U. SCHWABE ; I. TEIXERA ; L. TILSON ; F. CANKAT TULUNAY ; V. VLAHOVIC-PALCEVSKI ; K. WENDYKOWSKA ; B. WETTERMARK ; C. ZARA ; L.L. GUSTAFSSON |Article
Financial incentives have been suggested to be effective in increasing the quality and efficiency of drug prescribing. Concern has been raised in relation to potential negative consequences on the quality of care. This article aims to describe a[...]Article
Article
B. GODMAN ; B. WETTERMARK ; M. VAN WOERKOM ; J. FRAEYMAN ; S. ALVAREZ-MADRAZO ; C. BERG ; I. BISHOP ; A. BUSCICS ; S. CAMPBELL ; A.E. FINLAYSON ; J. FURST ; K. GARUOLIENE ; H. HERHOLZ ; M. KALABA ; O. LAIUS ; J. PIESSNEGGER ; C. SERMET ; U. SCHWABE ; V. VLAHOVIC-PALCEVSKI ; V. MARKOVIC-PEKOVIC ; L. VONCINA ; K. MALINOWSKA ; C. ZARA ; L.L. GUSTAFSSON |The appreciable growth in pharmaceutical expenditure has resulted in multiple initiatives across Europe to lower generic prices and enhance their utilization. However, considerable variation in their use and prices. Assess the influence of multi[...]Article
B. GODMAN ; W. SHRANK ; B. WETTERMARK ; M. ANDERSEN ; I. BISHOP ; T. BURKHARDT ; K. GARUOLIENE ; M. KALABA ; O. LAIUS ; R. JOPPI ; C. SERMET ; U. SCHWABE ; I. TEIXEIRA ; C. TULUNAY ; K. WENDYKOWSKA ; C. ZARA ; L.L. GUSTAFSSON |Pharmaceutical expenditures in ambulatory care rose rapidly in Europe in the 1990s and early 2000s. This was typically faster than other components of healthcare spending, leading to reforms to moderate future growth. A number of these centered [...]